Previously, we have shown that IFNβ, which is used as maintenance therapy in the treatment of children and adolescents with NPC, increases the ability of patients’ NK cells to kill NPC cells in vitro [15]. Here, IFNB1 is linked to nasopharyngeal carcinoma.